Meredith Rosenthal
Primary Faculty

Meredith Rosenthal

C. Boyden Gray Professor of Health Economics and Policy

Health Policy and Management


Dr. Rosenthal received her B.A. in International Relations (Commerce) from Brown University in 1990 and her Ph.D. in Health Policy (Economics track) from Harvard University in 1998.

Her research focuses primarily on policies that are designed to improve the affordability and value of health care in the United States. These efforts include changes in payment incentives, benefit design, and the provision of information and behavioral "nudges" to both patients and providers. Her research has influenced the design of provider payment systems in both the public and private sectors. She has advised federal and state policymakers in healthcare payment policy and implementation. She has also testified in Congressional hearings on direct-to-consumer advertising of prescription drugs and pay-for-performance and in legislative hearings in California and Massachusetts concerning healthcare provider payment and benefit design policies.

Dr. Rosenthal's work has been published in the New England Journal of Medicine, the Journal of the American Medical Association, Health Affairs, and numerous other peer-reviewed journals. In 2014, Dr. Rosenthal was elected to the National Academy of Medicine. Since 2016, Dr. Rosenthal has served as a member of the Massachusetts Center for Healthcare Information and Analysis Oversight Board.

Dr. Rosenthal is the Director of Graduate Studies for the Harvard PhD Program in Health Policy and the Faculty Chair for Harvard’s Advanced Leadership Initiative.



What would health care reform mean for Massachusetts hospitals?

Nearly every hospital in Massachusetts would be affected by the different health care reform policies currently being debated by Democratic presidential candidates because Medicare almost always pays hospitals less than private health insurance companies, according to a February…

Exploring solutions to the opioid epidemic

Nearly 100 researchers, health professionals, policymakers and community members gathered in Ypsilanti, Michigan on Friday, May 10, 2019 for a daylong summit, cosponsored by Harvard University and the University of Michigan, aimed at finding scalable solutions to the…

Rise in medical marketing could lead to health harms

Companies spent nearly $10 billion to market prescription drugs and medical services in 2016—five times more than they spent 20 years ago, according to a new study. The large increase in “medical marketing” includes ads directed at consumers…